Unknown

Dataset Information

0

DNA methylation signatures in peripheral blood strongly predict all-cause mortality.


ABSTRACT: DNA methylation (DNAm) has been revealed to play a role in various diseases. Here we performed epigenome-wide screening and validation to identify mortality-related DNAm signatures in a general population-based cohort with up to 14 years follow-up. In the discovery panel in a case-cohort approach, 11,063 CpGs reach genome-wide significance (FDR<0.05). 58 CpGs, mapping to 38 well-known disease-related genes and 14 intergenic regions, are confirmed in a validation panel. A mortality risk score based on ten selected CpGs exhibits strong association with all-cause mortality, showing hazard ratios (95% CI) of 2.16 (1.10-4.24), 3.42 (1.81-6.46) and 7.36 (3.69-14.68), respectively, for participants with scores of 1, 2-5 and 5+ compared with a score of 0. These associations are confirmed in an independent cohort and are independent from the 'epigenetic clock'. In conclusion, DNAm of multiple disease-related genes are strongly linked to mortality outcomes. The DNAm-based risk score might be informative for risk assessment and stratification.

SUBMITTER: Zhang Y 

PROVIDER: S-EPMC5357865 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

DNA methylation signatures in peripheral blood strongly predict all-cause mortality.

Zhang Yan Y   Wilson Rory R   Heiss Jonathan J   Breitling Lutz P LP   Saum Kai-Uwe KU   Schöttker Ben B   Holleczek Bernd B   Waldenberger Melanie M   Peters Annette A   Brenner Hermann H  

Nature communications 20170317


DNA methylation (DNAm) has been revealed to play a role in various diseases. Here we performed epigenome-wide screening and validation to identify mortality-related DNAm signatures in a general population-based cohort with up to 14 years follow-up. In the discovery panel in a case-cohort approach, 11,063 CpGs reach genome-wide significance (FDR<0.05). 58 CpGs, mapping to 38 well-known disease-related genes and 14 intergenic regions, are confirmed in a validation panel. A mortality risk score bas  ...[more]

Similar Datasets

| S-EPMC7442697 | biostudies-literature
| S-EPMC4350614 | biostudies-literature
| S-EPMC6293604 | biostudies-literature
| S-EPMC9304422 | biostudies-literature
| S-EPMC7382833 | biostudies-literature
| S-EPMC7083145 | biostudies-literature
| S-EPMC11324342 | biostudies-literature
| S-EPMC7686703 | biostudies-literature
| S-EPMC3262037 | biostudies-literature
| S-EPMC9503775 | biostudies-literature